Half-Life of NPH Insulin
NPH (Neutral Protamine Hagedorn) insulin has a half-life of approximately 6.6 hours, with its peak effect occurring around 8-12 hours after injection and a total duration of action of about 18-24 hours. 1, 2
Pharmacokinetic Profile of NPH Insulin
- NPH insulin begins to lower blood glucose approximately 1-2 hours after subcutaneous injection 1
- Peak effect occurs at approximately 8-12 hours after injection 3, 1
- Total duration of action is approximately 18-24 hours, with studies showing a range of 20-29 hours 1
- The half-life of NPH insulin in subcutaneous tissue has been measured at 6.6 ± 3.3 hours 2
Clinical Implications of NPH Pharmacokinetics
Advantages
- Intermediate-acting profile makes it suitable for basal insulin coverage
- Can be administered once or twice daily depending on patient needs
- Can be mixed with short-acting or rapid-acting insulins for combined coverage 3, 4
Disadvantages
- The pronounced peak at 8-12 hours increases risk of hypoglycemia, particularly when administered at bedtime 3
- More variable absorption compared to newer basal insulin analogs
- In elderly patients, NPH has been associated with higher rates of hypoglycemia compared to basal-bolus regimens with insulin analogs 3, 4
Practical Applications
Dosing Considerations
- When used as basal insulin, NPH is typically administered as:
- Once daily: Usually in the morning or at bedtime
- Twice daily: Typically 2/3 in the morning and 1/3 in the evening 4
- Initial dosing can start at 0.1-0.2 units/kg per day with titration based on glucose patterns 4
Mixing Guidelines
- NPH can be mixed with rapid-acting or short-acting insulins 3, 4
- When mixed with rapid-acting insulin, the mixture should be injected within 15 minutes before a meal 3, 4
- NPH should NOT be mixed with lente insulins due to potential precipitation of zinc phosphate 3, 4
- Currently available NPH and short-acting insulin formulations when mixed may be used immediately or stored for future use 3
Important Considerations
- The pronounced peak of NPH insulin at 8-12 hours can lead to nocturnal hypoglycemia when administered at bedtime 3, 5
- Newer long-acting insulin analogs (like insulin glargine) offer a smoother time-action profile with less pronounced peaks compared to NPH 5, 6
- Storage conditions affect potency: NPH insulin should be stored according to manufacturer guidelines, typically refrigerated when not in use 3
- Visual inspection before use is important: NPH insulin should appear uniformly cloudy; any clumping, frosting, precipitation, or change in clarity may indicate loss of potency 3
Clinical Pitfalls to Avoid
- Assuming NPH has a consistent effect throughout its duration of action (it has a pronounced peak)
- Failing to account for the peak action when timing doses relative to meals and sleep
- Overlooking the increased hypoglycemia risk in elderly patients using NPH compared to newer insulin analogs 3, 4
- Inappropriate mixing with other insulin types (particularly lente insulins) 3, 4